English

ORAPHARMA INC

EDGAR

Quarterly report (10-Q) · filed 2002-11-06

12 filing records in this dataset, filed from 2000-05-12 to 2002-11-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Insider filings have not been processed for this company yet.

See all insider transactions

Latest quarter

Revenue

5.46 million USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 5459501 USD Source

Operating margin

-92.6%

2002-09-30 · %

Exact inputs and evidence

Operating Income: -5055318 USD Source
Revenue: 5459501 USD Source

Operating cash flow

-3.85 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -15385068 USD Source
Operating Cash Flow: -11534140 USD Source

Free cash flow

-4.33 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -15385068 USD Source
Operating Cash Flow: -11534140 USD Source
Capital Expenditure: 1233273 USD Source
Capital Expenditure: 756924 USD Source

Cash and cash equivalents: 12.7 million USD 2002-09-30 Source
Exact value

12737266 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.3 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 7748405 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 4224450 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 4153646 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 5139308 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 5459501 USD · 2002-07-01 – 2002-09-30 Source

Net income

-22.5 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -25685660 USD · 2001-01-01 – 2001-12-31 Source
Net income: -19946209 USD · 2001-01-01 – 2001-09-30 Source
Net income: -6602682 USD · 2002-01-01 – 2002-03-31 Source
Net income: -5209957 USD · 2002-04-01 – 2002-06-30 Source
Net income: -4903512 USD · 2002-07-01 – 2002-09-30 Source

Operating cash flow

-19.9 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -24939191 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -20437948 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -6590852 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -11534140 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -6590852 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -15385068 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -11534140 USD · 2002-01-01 – 2002-06-30 Source

Capital expenditure

1.68 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Capital expenditure: 3664533 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 3222399 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 434550 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 756924 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 434550 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 1233273 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 756924 USD · 2002-01-01 – 2002-06-30 Source

Free cash flow

-21.6 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -24939191 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -20437948 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -6590852 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -11534140 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -6590852 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -15385068 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -11534140 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 3664533 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 3222399 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 434550 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 756924 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 434550 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 1233273 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 756924 USD · 2002-01-01 – 2002-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-11-06.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2001-12-31
Operating income: 3 of 11 periods available· newest 2001-12-31
Net income: 3 of 11 periods available· newest 2001-12-31
Operating cash flow: 3 of 11 periods available· newest 2001-12-31
Capital expenditure: 3 of 11 periods available· newest 2001-12-31
Total assets: 3 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 3 of 11 periods available· newest 2001-12-31
Current liabilities: 3 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+USD 7.75 million

Prior period

USD 0

2000-01-01 – 2000-12-31
Current period

USD 7.75 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

7748405 − 0 = 7748405 USD

0 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
7748405 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Year-over-year change in Revenue: 7748405 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7748405 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#2874 Input fundies:Revenue: 0 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#2874
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 13.37 million

Prior period

−USD 12.32 million

2000-01-01 – 2000-12-31
Current period

−USD 25.69 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-25685660 − -12316512 = -13369148 USD

-12316512 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-25685660 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Year-over-year change in Net income: -13369148 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -25685660 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3010 Input fundies:NetIncome: -12316512 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3010
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 15.5 million

Prior period

−USD 9.44 million

2000-01-01 – 2000-12-31
Current period

−USD 24.94 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-24939191 − -9440267 = -15498924 USD

-9440267 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-24939191 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Year-over-year change in Operating cash flow: -15498924 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -24939191 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 Input fundies:OperatingCashFlow: -9440267 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+3.8%

Prior period

USD 3.53 million

2000-01-01 – 2000-12-31
Current period

USD 3.66 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

3664533 − 3528685 = 135848 USD

3528685 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
3664533 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Year-over-year change in Capital expenditure: 135848 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3664533 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 Input fundies:CapitalExpenditure: 3528685 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 7.75 million 100% of revenue
Cost of revenue USD 1.96 million 25% of revenue
Operating expenses USD 33.96 million 438% of revenue
Operating income −USD 28.16 million −363% of revenue
Tax, interest and other Derived −USD 2.48 million −32% of revenue
Net income −USD 25.69 million −331% of revenue

Cash

Operating cash flow −USD 24.94 million −322% of revenue
Capital expenditure USD 3.66 million 47% of revenue
Free cash flow Derived −USD 28.6 million −369% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Operating loss: operating costs were 463% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	0	11882990 Derived	-11882990	-636957 Derived	-11246033	-11128232 Derived	Source 1999-01-01 – 1999-12-31: 0 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -11882990 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -11246033 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -10891287 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 236945 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	0	16555909 Derived	-16555909	-4239397 Derived	-12316512	-12968952 Derived	Source 2000-01-01 – 2000-12-31: 0 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -16555909 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -12316512 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -9440267 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 3528685 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	7748405	35913040 Derived	-28164635	-2478975 Derived	-25685660	-28603724 Derived	Source 2001-01-01 – 2001-12-31: 7748405 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -28164635 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -25685660 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -24939191 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 3664533 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.7M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	0	Revenue: 0 Open source
20002000-12-31	Revenue	0	Revenue: 0 Open source
20012001-12-31	Revenue	7748405	Revenue: 7748405 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20002000-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20012001-12-31	Year over year	No prior comparable period	Revenue: 7748405 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -363.5% 2001

Net margin -331.5% 2001

Free cash flow margin -369.2% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	Not reported	Operating Income: -11882990 Open source Revenue: 0 Open source
20002000-12-31	Operating margin	Not reported	Operating Income: -16555909 Open source Revenue: 0 Open source
20012001-12-31	Operating margin	-363.5%	Operating Income: -28164635 Open source Revenue: 7748405 Open source
19991999-12-31	Net margin	Not reported	Net Income: -11246033 Open source Revenue: 0 Open source
20002000-12-31	Net margin	Not reported	Net Income: -12316512 Open source Revenue: 0 Open source
20012001-12-31	Net margin	-331.5%	Net Income: -25685660 Open source Revenue: 7748405 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -10891287 Open source Capital Expenditure: 236945 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9440267 Open source Capital Expenditure: 3528685 Open source
20012001-12-31	Free cash flow margin	-369.2%	Revenue: 7748405 Open source Operating Cash Flow: -24939191 Open source Capital Expenditure: 3664533 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -24.9M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-10891287	Operating Cash Flow: -10891287 Open source
20002000-12-31	Operating cash flow	-9440267	Operating Cash Flow: -9440267 Open source
20012001-12-31	Operating cash flow	-24939191	Operating Cash Flow: -24939191 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -28.6M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	-11128232	Operating Cash Flow: -10891287 Open source Capital Expenditure: 236945 Open source
20002000-12-31	Free cash flow	-12968952	Operating Cash Flow: -9440267 Open source Capital Expenditure: 3528685 Open source
20012001-12-31	Free cash flow	-28603724	Operating Cash Flow: -24939191 Open source Capital Expenditure: 3664533 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 14711739 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 80431518 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 57749896 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.24× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	6.56×	Current Assets: 13559759 Open source Current Liabilities: 2066166 Open source
20002000-12-31	Current assets / current liabilities	19.12×	Current Assets: 75689733 Open source Current Liabilities: 3959124 Open source
20012001-12-31	Current assets / current liabilities	7.24×	Current Assets: 48276868 Open source Current Liabilities: 6668695 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 11.25 million Exact value Exact value: -11246033 USD 1999-01-01 – 1999-12-31: -11246033 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORAPHARMA INC · 1999-12-31 ORAPHARMA INC (edgar:1028065) Net Income: -11246033 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11246033 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3010 The citation records this snapshot. The page link may show a newer release later.	−USD 10.89 million Exact value Exact value: -10891287 USD 1999-01-01 – 1999-12-31: -10891287 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORAPHARMA INC · 1999-12-31 ORAPHARMA INC (edgar:1028065) Operating Cash Flow: -10891287 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10891287 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 The citation records this snapshot. The page link may show a newer release later.	USD 236,945 Exact value Exact value: 236945 USD 1999-01-01 – 1999-12-31: 236945 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORAPHARMA INC · 1999-12-31 ORAPHARMA INC (edgar:1028065) Capital Expenditure: 236945 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 236945 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.	−USD 11.13 million Calculation and evidence -10891287 − 236945 USD Exact free cash flow: -11128232 USD 1999-01-01 – 1999-12-31: -10891287 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 236945 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORAPHARMA INC · 1999-12-31 ORAPHARMA INC (edgar:1028065) Free cash flow: -11128232 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10891287 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 Input fundies:CapitalExpenditure: 236945 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 12.32 million Exact value Exact value: -12316512 USD 2000-01-01 – 2000-12-31: -12316512 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORAPHARMA INC · 2000-12-31 ORAPHARMA INC (edgar:1028065) Net Income: -12316512 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12316512 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3010 The citation records this snapshot. The page link may show a newer release later.	−USD 9.44 million Exact value Exact value: -9440267 USD 2000-01-01 – 2000-12-31: -9440267 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORAPHARMA INC · 2000-12-31 ORAPHARMA INC (edgar:1028065) Operating Cash Flow: -9440267 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9440267 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 The citation records this snapshot. The page link may show a newer release later.	USD 3.53 million Exact value Exact value: 3528685 USD 2000-01-01 – 2000-12-31: 3528685 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORAPHARMA INC · 2000-12-31 ORAPHARMA INC (edgar:1028065) Capital Expenditure: 3528685 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3528685 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.	−USD 12.97 million Calculation and evidence -9440267 − 3528685 USD Exact free cash flow: -12968952 USD 2000-01-01 – 2000-12-31: -9440267 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 3528685 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORAPHARMA INC · 2000-12-31 ORAPHARMA INC (edgar:1028065) Free cash flow: -12968952 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9440267 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 Input fundies:CapitalExpenditure: 3528685 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 25.69 million Exact value Exact value: -25685660 USD 2001-01-01 – 2001-12-31: -25685660 USD Inspect Net Income Open source Share or cite Citation for Net Income · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Net Income: -25685660 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25685660 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3010 The citation records this snapshot. The page link may show a newer release later.	−USD 24.94 million Exact value Exact value: -24939191 USD 2001-01-01 – 2001-12-31: -24939191 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Operating Cash Flow: -24939191 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24939191 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 The citation records this snapshot. The page link may show a newer release later.	USD 3.66 million Exact value Exact value: 3664533 USD 2001-01-01 – 2001-12-31: 3664533 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Capital Expenditure: 3664533 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3664533 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.	−USD 28.6 million Calculation and evidence -24939191 − 3664533 USD Exact free cash flow: -28603724 USD 2001-01-01 – 2001-12-31: -24939191 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 3664533 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ORAPHARMA INC · 2001-12-31 ORAPHARMA INC (edgar:1028065) Free cash flow: -28603724 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T11:04:53Z Snapshot: b22e7048fe243895443124201b14e65bd88999beadfa18ee12fabf0b4d13d3f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1028065?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24939191 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3028 Input fundies:CapitalExpenditure: 3664533 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1028065/0001045969-02-000489.txt#3031 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-14. Source filing dates and reporting periods are shown separately.

Identifiers: 0001028065, 1028065, edgar:1028065

ORAPHARMA INC

Holdings and insider activity

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation